Advertisement

Corneal Edema and Opacification Preferred Practice Pattern®

Published:October 23, 2018DOI:https://doi.org/10.1016/j.ophtha.2018.10.022
      AMERICAN ACADEMY™ OF OPHTHALMOLOGY
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook.
        SIGN, Edinburgh2015 (SIGN publication no. 50). [November 2015].
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE Working Group
        Organizations that have endorsed or that are using GRADE.
        http://www.gradeworkinggroup.org/
        Date accessed: September 19, 2018
        • Schmid KE
        • Kornek GV
        • Scheithauer W
        • Binder S
        Update on ocular complications of systemic cancer chemotherapy.
        Surv Ophthalmol. 2006; 51: 19-40
        • Feder RS
        • Olsen TW
        • Prum Jr., BE
        • et al.
        Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern((R)) Guidelines.
        Ophthalmology. 2016; 123 (or): P209-236
        www.aao.org/ppp
        Date accessed: May 23, 2017
        • Nevyas AS
        • Raber IM
        • Eagle Jr., RC
        • Wallace IB
        • Nevyas HJ
        Acute band keratopathy following intracameral Viscoat.
        Arch Ophthalmol. 1987; 105: 958-964
        • Freddo TF
        • Leibowitz HM
        Bilateral acute corneal calcification.
        Ophthalmology. 1985; 92: 537-542
        • Honig MA
        • Barraquer J
        • Perry HD
        • Riquelme JL
        • Green WR
        Forceps and vacuum injuries to the cornea: histopathologic features of twelve cases and review of the literature.
        Cornea. 1996; 15: 463-472
        • Gahl WA
        • Kuehl EM
        • Iwata F
        • Lindblad A
        • Kaiser-Kupfer MI
        Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
        Mol Genet Metab. 2000; 71: 100-120
        • Summers CG
        • Purple RL
        • Krivit W
        • et al.
        Ocular changes in the mucopolysaccharidoses after bone marrow transplantation. A preliminary report.
        Ophthalmology. 1989; 96 (discussion 984-975.): 977-984
        • van der Meulen IJ
        • Patel SV
        • Lapid-Gortzak R
        • Nieuwendaal CP
        • McLaren JW
        • van den Berg TJ
        Quality of vision in patients with Fuchs endothelial dystrophy and after Descemet stripping endothelial keratoplasty.
        Arch Ophthalmol. 2011; 129: 1537-1542
        • Wacker K
        • McLaren JW
        • Amin SR
        • Baratz KH
        • Patel SV
        Corneal high-order aberrations and backscatter in Fuchs' endothelial corneal dystrophy.
        Ophthalmology. 2015; 122: 1645-1652
        • Jeng BH
        • Galor A
        • Lee MS
        • et al.
        Amantadine-associated corneal edema potentially irreversible even after cessation of the medication.
        Ophthalmology. 2008; 115: 1540-1544
        • Naumann GO
        • Schlotzer-Schrehardt U
        Amantadine-associated corneal edema.
        Ophthalmology. 2009; 116 (author reply 1231.): 1230-1231
        • Park CY
        • Chuck RS
        Sudden bilateral corneal oedema in a patient with Parkinson's disease.
        Acta Ophthalmol. 2011; 89: 198-199
        • Varley GA
        • Meisler DM
        • Benes SC
        • McMahon JT
        • Zakov ZN
        • Fryczkowski A
        Hibiclens keratopathy: a clinicopathologic case report.
        Cornea. 1990; 9: 341-346
        • Raizman MB
        • Hamrah P
        • Holland EJ
        • et al.
        Drug-induced corneal epithelial changes.
        Surv Ophthalmol. 2017; 62: 286-301
        • Li J
        • Tripathi RC
        • Tripathi BJ
        Drug-induced ocular disorders.
        Drug Saf. 2008; 31: 127-141
        • Kaplan LJ
        • Cappaert WE
        Amiodarone keratopathy. Correlation to dosage and duration.
        Arch Ophthalmol. 1982; 100: 601-602
        • Jhanji V
        • Rapuano CJ
        • Vajpayee RB
        Corneal calcific band keratopathy.
        Curr Opin Ophthalmol. 2011; 22: 283-289
        • Jeganathan VS
        • Wirth A
        • MacManus MP
        Ocular risks from orbital and periorbital radiation therapy: a critical review.
        Int J Radiat Oncol Biol Phys. 2011; 79: 650-659
        • Smith GT
        • Deutsch GP
        • Cree IA
        • Liu CS
        Permanent corneal limbal stem cell dysfunction following radiotherapy for orbital lymphoma.
        Eye (Lond). 2000; 14: 905-907
        • Papathanassiou M
        • Nikita E
        • Theodossiadis P
        • Theodossiadis GP
        • Vergados I
        Exemestane-induced corneal epithelial changes.
        Cutan Ocul Toxicol. 2010; 29: 209-211
        • Yeh S
        • Fine HA
        • Smith JA
        Corneal verticillata after dual anti-epidermal growth factor receptor and antivascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma.
        Cornea. 2009; 28: 699-702
        • Van Meter WS
        Central corneal opacification resulting from recent chemotherapy in corneal donors.
        Trans Am Ophthalmol Soc. 2007; 105 (discussion 212-203.): 207-212
        • Serle JB
        • Katz LJ
        • McLaurin E
        • et al.
        Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2).
        Am J Ophthalmol. 2018; 186: 116-127
        • Miglior S
        • Albe E
        • Guareschi M
        • Mandelli G
        • Gomarasca S
        • Orzalesi N
        Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness.
        Br J Ophthalmol. 2004; 88: 174-177
        • Garcia-Medina JJ
        • Garcia-Medina M
        • Garcia-Maturana C
        • Zanon-Moreno V
        • Pons-Vazquez S
        • Pinazo-Duran MD
        Comparative study of central corneal thickness using fourier-domain optical coherence tomography versus ultrasound pachymetry in primary open-angle glaucoma.
        Cornea. 2013; 32: 9-13
        • Fante RJ
        • Shtein RM
        • Titus MS
        • Woodward MA
        Anterior segment optical coherence tomography versus ultrasound pachymetry to measure corneal thickness in endothelial keratoplasty donor corneas.
        Cornea. 2013; 32: e79-82
        • Wirbelauer C
        • Scholz C
        • Hoerauf H
        • Pham DT
        • Laqua H
        • Birngruber R
        Noncontact corneal pachymetry with slit lamp-adapted optical coherence tomography.
        Am J Ophthalmol. 2002; 133: 444-450
        • Zhao PS
        • Wong TY
        • Wong WL
        • Saw SM
        • Aung T
        Comparison of central corneal thickness measurements by visante anterior segment optical coherence tomography with ultrasound pachymetry.
        Am J Ophthalmol. 2007; 143: 1047-1049
        • Kim HY
        • Budenz DL
        • Lee PS
        • Feuer WJ
        • Barton K
        Comparison of central corneal thickness using anterior segment optical coherence tomography vs ultrasound pachymetry.
        Am J Ophthalmol. 2008; 145: 228-232
        • Brandt JD
        • Beiser JA
        • Kass MA
        • Gordon MO
        • Ocular Hypertension Treatment Study (OHTS) Group
        Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).
        Ophthalmology. 2001; 108: 1779-1788
        • Iyamu E
        • Osuobeni E
        Age, gender, corneal diameter, corneal curvature and central corneal thickness in Nigerians with normal intra ocular pressure.
        J Optom. 2012; 5: 87-97
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern® Guidelines. Corneal Ectasia.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Hirst LW
        • Yamauchi K
        • Enger C
        • Vogelpohl W
        • Whittington V
        Quantitative analysis of wide-field specular microscopy. II. Precision of sampling from the central corneal endothelium.
        Invest Ophthalmol Vis Sci. 1989; 30: 1972-1979
        • Mustonen RK
        • McDonald MB
        • Srivannaboon S
        • Tan AL
        • Doubrava MW
        • Kim CK
        In vivo confocal microscopy of Fuchs' endothelial dystrophy.
        Cornea. 1998; 17: 493-503
        • Edelhauser HF
        The balance between corneal transparency and edema: the Proctor Lecture.
        Invest Ophthalmol Vis Sci. 2006; 47: 1754-1767
        • Alm A
        • Grierson I
        • Shields MB
        Side effects associated with prostaglandin analog therapy.
        Surv Ophthalmol. 2008; 53: S93-105
        • Aydin S
        • Ozcura F
        Corneal oedema and acute anterior uveitis after two doses of travoprost.
        Acta Ophthalmol Scand. 2007; 85: 693-694
        • Wirtitsch MG
        • Findl O
        • Heinzl H
        • Drexler W
        Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
        Arch Ophthalmol. 2007; 125: 1345-1350
        • Egan CA
        • Hodge DO
        • McLaren JW
        • Bourne WM
        Effect of dorzolamide on corneal endothelial function in normal human eyes.
        Invest Ophthalmol Vis Sci. 1998; 39: 23-29
        • Foulks GN
        • Harvey T
        • Raj CV
        Therapeutic contact lenses: the role of high-Dk lenses.
        Ophthalmol Clin North Am. 2003; 16: 455-461
        • Luchs JI
        • Cohen EJ
        • Rapuano CJ
        • Laibson PR
        Ulcerative keratitis in bullous keratopathy.
        Ophthalmology. 1997; 104: 816-822
        • DeVoe AG
        Electrocautery of Bowman's membrane.
        Arch Ophthalmol. 1966; 76: 768-771
        • Cormier G
        • Brunette I
        • Boisjoly HM
        • LeFrancois M
        • Shi ZH
        • Guertin MC
        Anterior stromal punctures for bullous keratopathy.
        Arch Ophthalmol. 1996; 114: 654-658
        • Wood TO
        • McLaughlin BJ
        • Boykins LG
        Electron microscopy of corneal surface microdiathermy.
        Curr Eye Res. 1985; 4: 885-895
        • Maini R
        • Sullivan L
        • Snibson GR
        • Taylor HR
        • Loughnan MS
        A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy.
        Br J Ophthalmol. 2001; 85: 912-915
        • Rosa N
        • Cennamo G
        Phototherapeutic keratectomy for relief of pain in patients with pseudophakic corneal edema.
        J Refract Surg. 2002; 18: 276-279
        • Lin PY
        • Wu CC
        • Lee SM
        Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy.
        Br J Ophthalmol. 2001; 85: 908-911
        • Chawla B
        • Sharma N
        • Tandon R
        • Kalaivani M
        • Titiyal JS
        • Vajpayee RB
        Comparative evaluation of phototherapeutic keratectomy and amniotic membrane transplantation for management of symptomatic chronic bullous keratopathy.
        Cornea. 2010; 29: 976-979
        • Mannan R
        • Pruthi A
        • Rampal U
        Combined phototherapeutic keratectomy and amniotic membrane grafts for symptomatic bullous keratopathy.
        Cornea. 2010; 29 (author reply 1208-1209.): 1207-1208
        • Thomann U
        • Meier-Gibbons F
        • Schipper I
        Phototherapeutic keratectomy for bullous keratopathy.
        Br J Ophthalmol. 1995; 79: 335-338
        • Koenig SB
        Annular keratotomy for the treatment of painful bullous keratopathy.
        Am J Ophthalmol. 1996; 121: 93-94
        • Gundersen T
        Conjunctival flaps in the treatment of corneal disease with reference to a new technique of application.
        AMA Arch Ophthalmol. 1958; 60: 880-888
        • Guell JL
        • Morral M
        • Gris O
        • Elies D
        • Manero F
        Treatment of symptomatic bullous keratopathy with poor visual prognosis using a modified Gundersen conjunctival flap and amniotic membrane.
        Ophthalmic Surg Lasers Imaging. 2012; 43: 508-512
        • Sonmez B
        • Kim BT
        • Aldave AJ
        Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential.
        Cornea. 2007; 26: 227-229
        • Espana EM
        • Grueterich M
        • Sandoval H
        • et al.
        Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential.
        J Cataract Refract Surg. 2003; 29: 279-284
        • Pires RT
        • Tseng SC
        • Prabhasawat P
        • et al.
        Amniotic membrane transplantation for symptomatic bullous keratopathy.
        Arch Ophthalmol. 1999; 117: 1291-1297
        • Mejia LF
        • Santamaria JP
        • Acosta C
        Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane.
        Cornea. 2002; 21: 342-345
        • Georgiadis NS
        • Ziakas NG
        • Boboridis KG
        • Terzidou C
        • Mikropoulos DG
        Cryopreserved amniotic membrane transplantation for the management of symptomatic bullous keratopathy.
        Clin Experiment Ophthalmol. 2008; 36: 130-135
        • Pavlovic I
        • Shajari M
        • Herrmann E
        • Schmack I
        • Lencova A
        • Kohnen T
        Meta-analysis of postoperative outcome parameters comparing descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty.
        Cornea. 2017; 36: 1445-1451
        • Deng SX
        • Lee WB
        • Hammersmith KM
        • et al.
        Descemet membrane endothelial keratoplasty: safety and outcomes: a report by the american academy of ophthalmology.
        Ophthalmology. 2018; 125: 295-310
        • Streilein JW
        New thoughts on the immunology of corneal transplantation.
        Eye (Lond). 2003; 17: 943-948
        • Jonas JB
        • Rank RM
        • Budde WM
        Immunologic graft reactions after allogenic penetrating keratoplasty.
        Am J Ophthalmol. 2002; 133: 437-443
        • Claesson M
        • Armitage WJ
        • Fagerholm P
        • Stenevi U
        Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register.
        Br J Ophthalmol. 2002; 86: 174-180
        • Allan BD
        • Terry MA
        • Price Jr., FW
        • Price MO
        • Griffin NB
        • Claesson M
        Corneal transplant rejection rate and severity after endothelial keratoplasty.
        Cornea. 2007; 26: 1039-1042
        • Wu EI
        • Ritterband DC
        • Yu G
        • Shields RA
        • Seedor JA
        Graft rejection following descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes.
        Am J Ophthalmol. 2012; 153: 949-957
        • Jordan CS
        • Price MO
        • Trespalacios R
        • Price Jr., FW
        Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms.
        Br J Ophthalmol. 2009; 93: 387-390
        • Price MO
        • Gorovoy M
        • Benetz BA
        • et al.
        Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study.
        Ophthalmology. 2010; 117: 438-444
        • Price MO
        • Jordan CS
        • Moore G
        • Price Jr., FW
        Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors.
        Br J Ophthalmol. 2009; 93: 391-395
        • Price MO
        • Scanameo A
        • Feng MT
        • Price Jr., FW
        Descemet's membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids.
        Ophthalmology. 2016; 123: 1232-1236
        • Sugar A
        • Tanner JP
        • Dontchev M
        • Corneal Donor Study Investigator Group
        • et al.
        Recipient risk factors for graft failure in the cornea donor study.
        Ophthalmology. 2009; 116: 1023-1028
        • Price MO
        • Fairchild KM
        • Price DA
        • Price Jr., FW
        Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss.
        Ophthalmology. 2011; 118: 725-729
        • Thompson Jr., RW
        • Price MO
        • Bowers PJ
        • Price Jr., FW
        Long-term graft survival after penetrating keratoplasty.
        Ophthalmology. 2003; 110: 1396-1402
        • Elder MJ
        • Stack RR
        Globe rupture following penetrating keratoplasty: how often, why, and what can we do to prevent it?.
        Cornea. 2004; 23: 776-780
        • Perl T
        • Charlton KH
        • Binder PS
        Disparate diameter grafting. Astigmatism, intraocular pressure, and visual acuity.
        Ophthalmology. 1981; 88: 774-781
        • Samples JR
        • Binder PS
        Visual acuity, refractive error, and astigmatism following corneal transplantation for pseudophakic bullous keratopathy.
        Ophthalmology. 1985; 92: 1554-1560
        • Troutman RC
        • Gaster RN
        Surgical advances and results of keratoconus.
        Am J Ophthalmol. 1980; 90: 131-136
        • Perlman EM
        An analysis and interpretation of refractive errors after penetrating keratoplasty.
        Ophthalmology. 1981; 88: 39-45
        • Lee WB
        • Jacobs DS
        • Musch DC
        • Kaufman SC
        • Reinhart WJ
        • Shtein RM
        Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2009; 116: 1818-1830
        • Price MO
        • Baig KM
        • Brubaker JW
        • Price Jr., FW
        Randomized, prospective comparison of precut vs surgeon-dissected grafts for descemet stripping automated endothelial keratoplasty.
        Am J Ophthalmol. 2008; 146: 36-41
        • Covert DJ
        • Koenig SB
        New triple procedure: Descemet's stripping and automated endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation.
        Ophthalmology. 2007; 114: 1272-1277
        • Dickman MM
        • Kruit PJ
        • Remeijer L
        • et al.
        A randomized multicenter clinical trial of ultrathin descemet stripping automated endothelial keratoplasty (DSAEK) versus DSAEK.
        Ophthalmology. 2016; 123: 2276-2284
        • von Marchtaler PV
        • Weller JM
        • Kruse FE
        • Tourtas T
        Air versus sulfur hexafluoride gas tamponade in descemet membrane endothelial keratoplasty: a fellow eye comparison.
        Cornea. 2018; 37: 15-19
        • Oellerich S
        • Baydoun L
        • Peraza-Nieves J
        • et al.
        Multicenter study of 6-month clinical outcomes after descemet membrane endothelial keratoplasty.
        Cornea. 2017; 36: 1467-1476
        • Nagra PK
        • Hammersmith KM
        • Rapuano CJ
        • Laibson PR
        • Cohen EJ
        Wound dehiscence after penetrating keratoplasty.
        Cornea. 2006; 25: 132-135
        • Renucci AM
        • Marangon FB
        • Culbertson WW
        Wound dehiscence after penetrating keratoplasty: clinical characteristics of 51 cases treated at Bascom Palmer Eye Institute.
        Cornea. 2006; 25: 524-529
        • Ing JJ
        • Ing HH
        • Nelson LR
        • Hodge DO
        • Bourne WM
        Ten-year postoperative results of penetrating keratoplasty.
        Ophthalmology. 1998; 105: 1855-1865
        • Hamzaoglu EC
        • Straiko MD
        • Mayko ZM
        • Sales CS
        • Terry MA
        The first 100 eyes of standardized Descemet stripping automated endothelial keratoplasty versus standardized Descemet membrane endothelial keratoplasty.
        Ophthalmology. 2015; 122: 2193-2199
        • Price MO
        • Giebel AW
        • Fairchild KM
        • Price Jr., FW
        Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival.
        Ophthalmology. 2009; 116: 2361-2368
        • Dapena I
        • Ham L
        • Droutsas K
        • van Dijk K
        • Moutsouris K
        • Melles GR
        Learning curve in Descemet's membrane endothelial keratoplasty: first series of 135 consecutive cases.
        Ophthalmology. 2011; 118: 2147-2154
        • Anshu A
        • Price MO
        • Price Jr., FW
        Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty.
        Ophthalmology. 2012; 119: 536-540
        • Price MO
        • Lisek M
        • Feng MT
        • Price Jr., FW
        Effect of donor and recipient diabetes status on Descemet membrane endothelial keratoplasty adherence and survival.
        Cornea. 2017; 36: 1184-1188
        • Forster RK
        A comparison of two selective interrupted suture removal techniques for control of post keratoplasty astigmatism.
        Trans Am Ophthalmol Soc. 1997; 95 (discussion 214-120.): 193-214
        • Dirisamer M
        • Ham L
        • Dapena I
        • et al.
        Efficacy of Descemet membrane endothelial keratoplasty: clinical outcome of 200 consecutive cases after a learning curve of 25 cases.
        Arch Ophthalmol. 2011; 129: 1435-1443
        • Guerra FP
        • Anshu A
        • Price MO
        • Giebel AW
        • Price FW
        Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss.
        Ophthalmology. 2011; 118: 2368-2373
        • Serdarevic ON
        • Renard GJ
        • Pouliquen Y
        Randomized clinical trial of penetrating keratoplasty. Before and after suture removal comparison of intraoperative and postoperative suture adjustment.
        Ophthalmology. 1995; 102: 1497-1503
        • Bartels MC
        • van Rooij J
        • Geerards AJ
        • Mulder PG
        • Remeijer L
        Comparison of complication rates and postoperative astigmatism between nylon and mersilene sutures for corneal transplants in patients with Fuchs endothelial dystrophy.
        Cornea. 2006; 25: 533-539
        • Heidemann DG
        • Dunn SP
        • Chow CY
        Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy.
        Cornea. 2008; 27: 161-167
        • Ham L
        • Dapena I
        • Moutsouris K
        • et al.
        Refractive change and stability after Descemet membrane endothelial keratoplasty. Effect of corneal dehydration-induced hyperopic shift on intraocular lens power calculation.
        J Cataract Refract Surg. 2011; 37: 1455-1464
        • Lass JH
        • Gal RL
        • Dontchev M
        • Cornea Donor Study Investigator Group
        • et al.
        Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results.
        Ophthalmology. 2008; 115: 627-632
        • Ham L
        • van Luijk C
        • Dapena I
        • et al.
        Endothelial cell density after descemet membrane endothelial keratoplasty: 1- to 2-year follow-up.
        Am J Ophthalmol. 2009; 148: 521-527
        • Nanavaty MA
        • Wang X
        • Shortt AJ
        Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.
        Cochrane Database Syst Rev. 2014; CD008420
        • Eye Bank Association of America
        2016 Eye banking statistical report.
        • Price MO
        • Price Jr., FW
        Descemet's membrane endothelial keratoplasty surgery: update on the evidence and hurdles to acceptance.
        Curr Opin Ophthalmol. 2013; 24: 329-335
        • Yokogawa H
        • Sanchez PJ
        • Mayko ZM
        • Straiko MD
        • Terry MA
        Corneal astigmatism stability in descemet membrane endothelial keratoplasty for fuchs corneal dystrophy.
        Cornea. 2016; 35: 932-937
        • Veldman PB
        • Dye PK
        • Holiman JD
        • et al.
        The S-stamp in descemet membrane endothelial keratoplasty safely eliminates upside-down graft implantation.
        Ophthalmology. 2016; 123: 161-164
        • Ampazas P
        • Droutsas K
        • Giallouros E
        • Schroeder FM
        • Sekundo W
        Comparison of 5% sulfur hexafluoride versus 100% air tamponade in descemet membrane endothelial keratoplasty.
        Cornea. 2017; 36: 1189-1194
        • Moloney G
        • Petsoglou C
        • Ball M
        • et al.
        Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil.
        Cornea. 2017; 36: 642-648
        • Sanchez JC
        • Infantes Molina EJ
        • Cantos EA
        Descemetorhexis without graft placement: transplant of descemet-free fragments.
        Ophthalmology. 2017; 1241620
        • Kinoshita S
        • Koizumi N
        • Ueno M
        • et al.
        Injection of Cultured Cells with a ROCK Inhibitor for Bullous Keratopathy.
        N Engl J Med. 2018; 378: 995-1003
        • Turner A
        • Rabiu M
        Patching for corneal abrasion.
        Cochrane Database Syst Rev. 2006; CD004764
        • Federici TJ
        The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease.
        Pharmacol Res. 2011; 64: 614-623
        • Watson SL
        • Secker GA
        • Daniels JT
        The effect of therapeutic human serum drops on corneal stromal wound-healing activity.
        Curr Eye Res. 2008; 33: 641-652
        • Yoon KC
        • You IC
        • Im SK
        • Jeong TS
        • Park YG
        • Choi J
        Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis.
        Ophthalmology. 2007; 114: 1637-1642
        • Alió JL
        • Abad M
        • Artola A
        • Rodriguez-Prats JL
        • Pastor S
        • Ruiz-Colecha J
        Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers.
        Ophthalmology. 2007; 114: 1286-1293
        • Aloe L
        • Tirassa P
        • Lambiase A
        The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers.
        Pharmacol Res. 2008; 57: 253-258
        • Tan MH
        • Bryars J
        • Moore J
        Use of nerve growth factor to treat congenital neurotrophic corneal ulceration.
        Cornea. 2006; 25: 352-355
        • Chikama T
        • Fukuda K
        • Morishige N
        • Nishida T
        Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.
        Lancet. 1998; 351: 1783-1784
        • Nishida T
        The role of fibronectin in corneal wound healing explored by a physician-scientist.
        Jpn J Ophthalmol. 2012; 56: 417-431
        • Dunn SP
        • Heidemann DG
        • Chow CY
        • et al.
        Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4.
        Ann N Y Acad Sci. 2010; 1194: 199-206
        • Khokhar S
        • Natung T
        • Sony P
        • Sharma N
        • Agarwal N
        • Vajpayee RB
        Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial.
        Cornea. 2005; 24: 654-660
        • Solomon A
        • Meller D
        • Prabhasawat P
        • et al.
        Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers.
        Ophthalmology. 2002; 109: 694-703
        • Letko E
        • Stechschulte SU
        • Kenyon KR
        • et al.
        Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers.
        Arch Ophthalmol. 2001; 119: 659-663
        • Pachigolla G
        • Prasher P
        • Di Pascuale MA
        • McCulley JP
        • McHenry JG
        • Mootha VV
        Evaluation of the role of ProKera in the management of ocular surface and orbital disorders.
        Eye Contact Lens. 2009; 35: 172-175
        • Vote BJ
        • Elder MJ
        Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature.
        Clin Experiment Ophthalmol. 2000; 28: 437-442
        • Arslan S
        • Aydemir O
        • Guler M
        • Dagli AF
        Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
        Curr Eye Res. 2012; 37: 228-233
        • Baker R
        • Urso-Baiarda F
        • Linge C
        • Grobbelaar A
        Cutaneous scarring: a clinical review.
        Dermatol Res Pract. 2009; 2009625376
        • Blair J
        • Hodge W
        • Al-Ghamdi S
        • et al.
        Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial.
        Can J Ophthalmol. 2011; 46: 40-45
        • Srinivasan M
        • Mascarenhas J
        • Rajaraman R
        • Steroids for Corneal Ulcers Trial Group
        • et al.
        Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
        Arch Ophthalmol. 2012; 130: 143-150
        • Holló G
        Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules.
        Dev Ophthalmol. 2012; 50: 79-89
        • Zhong H
        • Sun G
        • Lin X
        • Wu K
        • Yu M
        Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
        Invest Ophthalmol Vis Sci. 2011; 52: 3136-3142
        • Prata Jr., JA
        • Seah SK
        • Minckler DS
        • Baerveldt G
        • Lee PP
        • Heuer DK
        Postoperative complications and short-term outcome after 5-Fluorouracil or mitomycin-C trabeculectomy.
        J Glaucoma. 1995; 4: 25-31
        • Abraham LM
        • Selva D
        • Casson R
        • Leibovitch I
        Mitomycin: clinical applications in ophthalmic practice.
        Drugs. 2006; 66: 321-340
        • Kim JH
        • Kim MJ
        • Kim DY
        • Kim JY
        • Tchah H
        Recurrent corneal hypertrophic scar after laser-assisted subepithelial keratectomy with mitomycin C treatment.
        Cornea. 2011; 30: 1030-1034
        • Farid M
        • Morishige N
        • Lam L
        • Wahlert A
        • Steinert RF
        • Jester JV
        Detection of corneal fibrosis by imaging second harmonic-generated signals in rabbit corneas treated with mitomycin C after excimer laser surface ablation.
        Invest Ophthalmol Vis Sci. 2008; 49: 4377-4383
        • Ehrlich MI
        • Phinney RB
        • Mondino BJ
        • Pettit TH
        Techniques of lamellar keratoplasty.
        Int Ophthalmol Clin. 1988; 28: 24-29
        • Wood TO
        • Walker GG
        Treatment of band keratopathy.
        Am J Ophthalmol. 1975; 80: 550
        • Elkins BS
        • Casebeer JC
        • Kezirian GM
        Sutureless homoplastic lamellar keratoplasty.
        J Refract Surg. 1997; 13: 185-187
        • Alió JL
        • Javaloy J
        • Merayo J
        • Galal A
        Automated superficial lamellar keratectomy augmented by excimer laser masked PTK in the management of severe superficial corneal opacities.
        Br J Ophthalmol. 2004; 88: 1289-1294
        • Buratto L
        • Brint SF
        • Ferrari M
        Complications.
        in: Buratto L Brint SF LASIK: Principles and Techniques. SLACK, Inc., Thorofare, NJ1998: 120-121
        • Alió JL
        • Agdeppa MC
        • Uceda-Montanes A
        Femtosecond laser-assisted superficial lamellar keratectomy for the treatment of superficial corneal leukomas.
        Cornea. 2011; 30: 301-307
        • Rasheed K
        • Rabinowitz YS
        Superficial lamellar keratectomy using an automated microkeratome to excise corneal scarring caused by photorefractive keratectomy.
        J Cataract Refract Surg. 1999; 25: 1184-1187
        • Najjar DM
        Management of band keratopathy with excimer phototherapeutic keratectomy.
        Eye (Lond). 2006; 20: 252
        • O'Brart DP
        • Gartry DS
        • Lohmann CP
        • Patmore AL
        • Kerr Muir MG
        • Marshall J
        Treatment of band keratopathy by excimer laser phototherapeutic keratectomy: surgical techniques and long term follow up.
        Br J Ophthalmol. 1993; 77: 702-708
        • Cavanaugh TB
        • Lind DM
        • Cutarelli PE
        • et al.
        Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy.
        Ophthalmology. 1999; 106: 971-976
        • Elsahn AF
        • Rapuano CJ
        • Antunes VA
        • Abdalla YF
        • Cohen EJ
        Excimer laser phototherapeutic keratectomy for keratoconus nodules.
        Cornea. 2009; 28: 144-147
        • Awdeh RM
        • Abbey AM
        • Vroman DT
        • et al.
        Phototherapeutic keratectomy for the treatment of subepithelial fibrosis and anterior corneal scarring after descemet stripping automated endothelial keratoplasty.
        Cornea. 2012; 31: 761-763
        • Stewart OG
        • Morrell AJ
        Management of band keratopathy with excimer phototherapeutic keratectomy: visual, refractive, and symptomatic outcome.
        Eye (Lond). 2003; 17: 233-237
        • Miller A
        • Solomon R
        • Bloom A
        • Palmer C
        • Perry HD
        • Donnenfeld ED
        Prevention of recurrent Reis-Bücklers dystrophy following excimer laser phototherapeutic keratectomy with topical mitomycin C.
        Cornea. 2004; 23: 732-735
        • Das S
        • Langenbucher A
        • Seitz B
        Excimer laser phototherapeutic keratectomy for granular and lattice corneal dystrophy: a comparative study.
        J Refract Surg. 2005; 21: 727-731
        • Vinciguerra P
        • Camesasca FI
        Custom phototherapeutic keratectomy with intraoperative topography.
        J Refract Surg. 2004; 20: S555-563
        • Ayres BD
        • Hammersmith KM
        • Laibson PR
        • Rapuano CJ
        Phototherapeutic keratectomy with intraoperative mitomycin C to prevent recurrent anterior corneal pathology.
        Am J Ophthalmol. 2006; 142: 490-492
        • Kim TI
        • Pak JH
        • Chae JB
        • Kim EK
        • Tchah H
        Mitomycin C inhibits recurrent Avellino dystrophy after phototherapeutic keratectomy.
        Cornea. 2006; 25: 220-223
        • Alió JL
        • Belda JI
        • Shalaby AM
        Correction of irregular astigmatism with excimer laser assisted by sodium hyaluronate.
        Ophthalmology. 2001; 108: 1246-1260
        • Dinh R
        • Rapuano CJ
        • Cohen EJ
        • Laibson PR
        Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy.
        Ophthalmology. 1999; 106: 1490-1497
        • Rapuano CJ
        Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: short-term clinical outcomes with and without an antihyperopia treatment and poor effectiveness of ultrasound biomicroscopic evaluation.
        Cornea. 2005; 24: 20-31
        • Najjar DM
        • Cohen EJ
        • Rapuano CJ
        • Laibson PR
        EDTA chelation for calcific band keratopathy: results and long-term follow-up.
        Am J Ophthalmol. 2004; 137: 1056-1064
        • Arjamaa O
        EDTA chelation for calcific band keratopathy.
        Am J Ophthalmol. 2005; 139 (author reply 216.): 216
        • Lombardo M
        • De Santo MP
        • Lombardo G
        • et al.
        Surface quality of femtosecond dissected posterior human corneal stroma investigated with atomic force microscopy.
        Cornea. 2012; 31: 1369-1375
        • Sarayba MA
        • Ignacio TS
        • Binder PS
        • Tran DB
        Comparative study of stromal bed quality by using mechanical, IntraLase femtosecond laser 15- and 30-kHz microkeratomes.
        Cornea. 2007; 26: 446-451
        • Jones MN
        • Armitage WJ
        • Ayliffe W
        • Larkin DF
        • Kaye SB
        Penetrating and deep anterior lamellar keratoplasty for keratoconus: a comparison of graft outcomes in the United Kingdom.
        Invest Ophthalmol Vis Sci. 2009; 50: 5625-5629
        • Shousha MA
        • Yoo SH
        • Kymionis GD
        • et al.
        Long-term results of femtosecond laser-assisted sutureless anterior lamellar keratoplasty.
        Ophthalmology. 2011; 118: 315-323
        • Hoffart L
        • Proust H
        • Matonti F
        • Catanese M
        • Conrath J
        • Ridings B
        Femtosecond-assisted anterior lamellar keratoplasty [in French].
        J Fr Ophtalmol. 2007; 30: 689-694
        • Mosca L
        • Fasciani R
        • Tamburelli C
        • et al.
        Femtosecond laser-assisted lamellar keratoplasty: early results.
        Cornea. 2008; 27: 668-672
        • Utine CA
        • Tzu JH
        • Akpek EK
        Lamellar keratoplasty using gamma-irradiated corneal lenticules.
        Am J Ophthalmol. 2011; 151: 170-174
        • Daoud YJ
        • Smith R
        • Smith T
        • Akpek EK
        • Ward DE
        • Stark WJ
        The intraoperative impression and postoperative outcomes of gamma-irradiated corneas in corneal and glaucoma patch surgery.
        Cornea. 2011; 30: 1387-1391
        • Stevenson W
        • Cheng SF
        • Emami-Naeini P
        • et al.
        Gamma-irradiation reduces the allogenicity of donor corneas.
        Invest Ophthalmol Vis Sci. 2012; 53: 7151-7158
        • Jhanji V
        • Sharma N
        • Vajpayee RB
        Management of keratoconus: current scenario.
        Br J Ophthalmol. 2011; 95: 1044-1050
        • Reinhart WJ
        • Musch DC
        • Jacobs DS
        • Lee WB
        • Kaufman SC
        • Shtein RM
        Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology.
        Ophthalmology. 2011; 118: 209-218
        • Feizi S
        • Javadi MA
        • Jamali H
        • Mirbabaee F
        Deep anterior lamellar keratoplasty in patients with keratoconus: big-bubble technique.
        Cornea. 2010; 29: 177-182
        • Buzzonetti L
        • Laborante A
        • Petrocelli G
        Refractive outcome of keratoconus treated by combined femtosecond laser and big-bubble deep anterior lamellar keratoplasty.
        J Refract Surg. 2011; 27: 189-194
        • Farid M
        • Steinert RF
        Deep anterior lamellar keratoplasty performed with the femtosecond laser zigzag incision for the treatment of stromal corneal pathology and ectatic disease.
        J Cataract Refract Surg. 2009; 35: 809-813
        • Ardjomand N
        • Hau S
        • McAlister JC
        • et al.
        Quality of vision and graft thickness in deep anterior lamellar and penetrating corneal allografts.
        Am J Ophthalmol. 2007; 143: 228-235
        • Al-Torbak AA
        • Al-Motowa S
        • Al-Assiri A
        • et al.
        Deep anterior lamellar keratoplasty for keratoconus.
        Cornea. 2006; 25: 408-412
        • Feizi S
        • Javadi MA
        • Rastegarpour A
        Visual acuity and refraction after deep anterior lamellar keratoplasty with and without successful big-bubble formation.
        Cornea. 2010; 29: 1252-1255
        • Fontana L
        • Parente G
        • Sincich A
        • Tassinari G
        Influence of graft-host interface on the quality of vision after deep anterior lamellar keratoplasty in patients with keratoconus.
        Cornea. 2011; 30: 497-502
        • Fontana L
        • Parente G
        • Tassinari G
        Clinical outcomes after deep anterior lamellar keratoplasty using the big-bubble technique in patients with keratoconus.
        Am J Ophthalmol. 2007; 143: 117-124
        • Han DC
        • Mehta JS
        • Por YM
        • Htoon HM
        • Tan DT
        Comparison of outcomes of lamellar keratoplasty and penetrating keratoplasty in keratoconus.
        Am J Ophthalmol. 2009; 148: 744-751
        • Javadi MA
        • Feizi S
        • Yazdani S
        • Mirbabaee F
        Deep anterior lamellar keratoplasty versus penetrating keratoplasty for keratoconus: a clinical trial.
        Cornea. 2010; 29: 365-371
        • Smadja D
        • Colin J
        • Krueger RR
        • et al.
        Outcomes of deep anterior lamellar keratoplasty for keratoconus: learning curve and advantages of the big bubble technique.
        Cornea. 2012; 31: 859-863
        • Kubaloglu A
        • Sari ES
        • Unal M
        • et al.
        Long-term results of deep anterior lamellar keratoplasty for the treatment of keratoconus.
        Am J Ophthalmol. 2011; 151: 760-767
        • Cheng YY
        • Visser N
        • Schouten JS
        • et al.
        Endothelial cell loss and visual outcome of deep anterior lamellar keratoplasty versus penetrating keratoplasty: a randomized multicenter clinical trial.
        Ophthalmology. 2011; 118: 302-309
        • Fogla R
        • Padmanabhan P
        Results of deep lamellar keratoplasty using the big-bubble technique in patients with keratoconus.
        Am J Ophthalmol. 2006; 141: 254-259
        • Kubaloglu A
        • Koytak A
        • Sari ES
        • Akyol S
        • Kurnaz E
        • Ozerturk Y
        Corneal endothelium after deep anterior lamellar keratoplasty and penetrating keratoplasty for keratoconus: a four-year comparative study.
        Indian J Ophthalmol. 2012; 60: 35-40
        • Sarnicola V
        • Toro P
        • Sarnicola C
        • Sarnicola E
        • Ruggiero A
        Long-term graft survival in deep anterior lamellar keratoplasty.
        Cornea. 2012; 31: 621-626
        • Olson EA
        • Tu EY
        • Basti S
        Stromal rejection following deep anterior lamellar keratoplasty: implications for postoperative care.
        Cornea. 2012; 31: 969-973
        • Parmar P
        • Salman A
        • Jesudasan CA
        Visual outcome and corneal topography after eccentric “shaped” corneal grafts.
        Cornea. 2009; 28: 379-384
        • Huang T
        • Wang Y
        • Ji J
        • Gao N
        • Chen J
        Evaluation of different types of lamellar keratoplasty for treatment of peripheral corneal perforation.
        Graefes Arch Clin Exp Ophthalmol. 2008; 246: 1123-1131
        • Afshari NA
        • Duncan SM
        • Tanhehco TY
        • Azar DT
        Optimal size and location for corneal rotational autografts: a simplified mathematical model.
        Arch Ophthalmol. 2006; 124: 410-413
        • Bertelmann E
        • Hartmann C
        • Scherer M
        • Rieck P
        Outcome of rotational keratoplasty: comparison of endothelial cell loss in autografts vs allografts.
        Arch Ophthalmol. 2004; 122: 1437-1440
        • Mashor RS
        • Rootman DB
        • Bahar I
        • Singal N
        • Slomovic AR
        • Rootman DS
        Outcomes of deep anterior lamellar keratoplasty versus intralase enabled penetrating keratoplasty in keratoconus.
        Can J Ophthalmol. 2011; 46: 403-407
        • Chamberlain WD
        • Rush SW
        • Mathers WD
        • Cabezas M
        • Fraunfelder FW
        Comparison of femtosecond laser-assisted keratoplasty versus conventional penetrating keratoplasty.
        Ophthalmology. 2011; 118: 486-491
        • Chan CC
        • Ritenour RJ
        • Kumar NL
        • Sansanayudh W
        • Rootman DS
        Femtosecond laser-assisted mushroom configuration deep anterior lamellar keratoplasty.
        Cornea. 2010; 29: 290-295
        • Ignacio TS
        • Nguyen TB
        • Chuck RS
        • Kurtz RM
        • Sarayba MA
        Top hat wound configuration for penetrating keratoplasty using the femtosecond laser: a laboratory model.
        Cornea. 2006; 25: 336-340
        • Kutzscher EM
        • Sorenson AL
        • Goodman DF
        Penetrating keratoplasty performed by residents.
        Arch Ophthalmol. 2004; 122: 1333-1336
        • Moorthy S
        • Graue E
        • Jhanji V
        • Constantinou M
        • Vajpayee RB
        Microbial keratitis after penetrating keratoplasty: impact of sutures.
        Am J Ophthalmol. 2011; 152 (e182.): 189-194
        • Hood CT
        • Lee BJ
        • Jeng BH
        Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty.
        Cornea. 2011; 30: 624-628
        • Chamberlain W
        • Omid N
        • Lin A
        • Farid M
        • Gaster RN
        • Steinert RF
        Comparison of corneal surface higher-order aberrations after endothelial keratoplasty, femtosecond laser-assisted keratoplasty, and conventional penetrating keratoplasty.
        Cornea. 2012; 31: 6-13
        • Armitage WJ
        • Dick AD
        • Bourne WM
        Predicting endothelial cell loss and long-term corneal graft survival.
        Invest Ophthalmol Vis Sci. 2003; 44: 3326-3331
        • Park CY
        • Lee JK
        • Gore PK
        • Lim CY
        • Chuck RS
        Keratoplasty in the United States: a 10-year review from 2005 through 2014.
        Ophthalmology. 2015; 122: 2432-2442
        • Aldave AJ
        • DeMatteo J
        • Glasser DB
        • et al.
        Report of the Eye Bank Association of America medical advisory board subcommittee on fungal infection after corneal transplantation.
        Cornea. 2013; 32: 149-154
        • Edelstein SL
        • DeMatteo J
        • Stoeger CG
        • Macsai MS
        • Wang CH
        Report of the Eye Bank Association of America medical review subcommittee on adverse reactions reported From 2007 to 2014.
        Cornea. 2016; 35: 917-926
        • Vislisel JM
        • Goins KM
        • Wagoner MD
        • et al.
        Incidence and outcomes of positive donor corneoscleral rim fungal cultures after keratoplasty.
        Ophthalmology. 2017; 124: 36-42
        • Brothers KM
        • Shanks RMQ
        • Hurlbert S
        • Kowalski RP
        • Tu EY
        Association between fungal contamination and eye bank-prepared endothelial keratoplasty tissue: temperature-dependent risk factors and antifungal supplementation of optisol-gentamicin and streptomycin.
        JAMA Ophthalmol. 2017; 135: 1184-1190
        • Wilhelmus KR
        • Hassan SS
        The prognostic role of donor corneoscleral rim cultures in corneal transplantation.
        Ophthalmology. 2007; 114: 440-445
        • Keyhani K
        • Seedor JA
        • Shah MK
        • Terraciano AJ
        • Ritterband DC
        The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty.
        Cornea. 2005; 24: 288-291
        • Barber JC
        Keratoprosthesis: past and present.
        Int Ophthalmol Clin. 1988; 28: 103-109
        • Cardona H
        • DeVoe AG
        Prosthokeratoplasty.
        Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977; 83: 271-280
        • Falcinelli G
        • Falsini B
        • Taloni M
        • Colliardo P
        Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases.
        Arch Ophthalmol. 2005; 123: 1319-1329
        • Hicks CR
        • Crawford GJ
        • Tan DT
        • et al.
        AlphaCor cases: comparative outcomes.
        Cornea. 2003; 22: 583-590
        • Pujari S
        • Siddique SS
        • Dohlman CH
        • Chodosh J
        The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
        Cornea. 2011; 30: 1298-1303
        • Aldave AJ
        • Kamal KM
        • Vo RC
        • Yu F
        The Boston type I keratoprosthesis: improving outcomes and expanding indications.
        Ophthalmology. 2009; 116: 640-651
        • Aldave AJ
        • Sangwan VS
        • Basu S
        • et al.
        International results with the Boston type I keratoprosthesis.
        Ophthalmology. 2012; 119: 1530-1538
        • Zerbe BL
        • Belin MW
        • Ciolino JB
        • Boston Type 1 Keratoprosthesis Study Group
        Results from the multicenter Boston Type 1 Keratoprosthesis Study.
        Ophthalmology. 2006; 1131779
        • Greiner MA
        • Li JY
        • Mannis MJ
        Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
        Ophthalmology. 2011; 118: 1543-1550
        • Harissi-Dagher M
        • Dohlman CH
        The Boston Keratoprosthesis in severe ocular trauma.
        Can J Ophthalmol. 2008; 43: 165-169
        • Iyer G
        • Srinivasan B
        • Gupta J
        • et al.
        Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
        Cornea. 2011; 30: 1083-1087
        • Khan BF
        • Harissi-Dagher M
        • Pavan-Langston D
        • Aquavella JV
        • Dohlman CH
        The Boston keratoprosthesis in herpetic keratitis.
        Arch Ophthalmol. 2007; 125: 745-749
        • Pavan-Langston D
        • Dohlman CH
        Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy.
        Ophthalmology. 2008; 115: S21-23
        • Akpek EK
        • Harissi-Dagher M
        • Petrarca R
        • et al.
        Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
        Am J Ophthalmol. 2007; 144: 227-231
        • Sayegh RR
        • Ang LP
        • Foster CS
        • Dohlman CH
        The Boston keratoprosthesis in Stevens-Johnson syndrome.
        Am J Ophthalmol. 2008; 145: 438-444
        • Bersudsky V
        • Blum-Hareuveni T
        • Rehany U
        • Rumelt S
        The profile of repeated corneal transplantation.
        Ophthalmology. 2001; 108: 461-469
        • Aquavella JV
        • Gearinger MD
        • Akpek EK
        • McCormick GJ
        Pediatric keratoprosthesis.
        Ophthalmology. 2007; 114: 989-994
        • Fung SSM
        • Jabbour S
        • Harissi-Dagher M
        • et al.
        Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review.
        Ophthalmology. 2018; 125: 153-160
        • Ciolino JB
        • Ament JW
        • Zerbe BL
        • Belin MW
        Etiology of keratoprosthesis loss: results from the Boston Keratoprosthesis Multicenter Study.
        Invest Ophthalmol Vis Sci. 2008; (E-Abstract 5712.): 49
        • Verdejo-Gomez L
        • Pelaez N
        • Gris O
        • Guell JL
        The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
        Ophthalmic Surg Lasers Imaging. 2011; 42: 446-452
        • Aravena C
        • Yu F
        • Aldave AJ
        Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis.
        Cornea. 2018; 37: 3-10
        • Dohlman CH
        • Grosskreutz CL
        • Chen TC
        • et al.
        Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery.
        J Glaucoma. 2010; 19: 111-115
        • Patel S
        • Takusagawa H
        • Shen L
        • Dohlman C
        • Grosskreutz C
        Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
        Am J Ophthalmol. 2012; 154 (author reply 208-209.): 207-208
        • Kamyar R
        • Weizer JS
        • de Paula FH
        • et al.
        Glaucoma associated with Boston type I keratoprosthesis.
        Cornea. 2012; 31: 134-139
        • Alexander JK
        • Basak SK
        • Padilla MD
        • Yu F
        • Aldave AJ
        International outcomes of the Boston type I keratoprosthesis in Stevens-Johnson syndrome.
        Cornea. 2015; 34: 1387-1394
        • Biber JM
        • Skeens HM
        • Neff KD
        • Holland EJ
        The Cincinnati procedure: technique and outcomes of combined living-related conjunctival limbal allografts and keratolimbal allografts in severe ocular surface failure.
        Cornea. 2011; 30: 765-771
        • Yaghouti F
        • Nouri M
        • Abad JC
        • Power WJ
        • Doane MG
        • Dohlman CH
        Keratoprosthesis: preoperative prognostic categories.
        Cornea. 2001; 20: 19-23
        • Barnes SD
        • Dohlman CH
        • Durand ML
        Fungal colonization and infection in Boston keratoprosthesis.
        Cornea. 2007; 26: 9-15
        • Mazzotta C
        • Traversi C
        • Baiocchi S
        • Barabino S
        • Mularoni A
        Phenotypic spectrum of granular corneal dystrophy type II in two italian families presenting an unusual granular corneal dystrophy type I clinical appearance.
        Case Rep Ophthalmol Med. 2015; 2015703418
        • Flaxman SR
        • Bourne RRA
        • Resnikoff S
        • et al.
        Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
        Lancet Glob Health. 2017; 5: e1221-e1234
        • Whitcher JP
        • Srinivasan M
        • Upadhyay MP
        Corneal blindness: a global perspective.
        Bull World Health Organ. 2001; 79: 214-221
        • Pascolini D
        • Mariotti SP
        Global estimates of visual impairment: 2010.
        Br J Ophthalmol. 2012; 96: 614-618
        • Oliva MS
        • Schottman T
        • Gulati M
        Turning the tide of corneal blindness.
        Indian J Ophthalmol. 2012; 60: 423-427

      Uncited Reference

        • Srikumaran D
        • Munoz B
        • Aldave AJ
        • et al.
        Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort.
        Ophthalmology. 2014; 121: 2159-2164

      Linked Article

      • Corrigendum
        OphthalmologyVol. 127Issue 5
        • Preview
          The article entitled, “Corneal Edema and Opacification Preferred Practice Pattern®” by Farid M, Rhee MK, Akpek EK, et al (Ophthalmology. 2019;126:P216-285) appeared in the January 2019 issue. The editors noted an error in the second paragraph on page P239, which should read as follows (changes in boldface):
        • Full-Text
        • PDF